Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib

Treatment with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has been shown to prolong survival in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). The present study performed a retrospective analysis to investigate the association between the plasma...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Clin Oncol
Главные авторы: INOMATA, MINEHIKO, HAYASHI, RYUJI, TANAKA, HIROAKI, SHIMOKAWA, KAZUKI, TOKUI, KOTARO, TAKA, CHIHIRO, OKAZAWA, SEISUKE, KAMBARA, KENTA, ICHIKAWA, TOMOMI, YAMADA, TORU, MIWA, TOSHIRO, KASHII, TATSUHIKO, MATSUI, SHOKO, TOBE, KAZUYUKI
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2016
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840529/
https://ncbi.nlm.nih.gov/pubmed/27123277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.779
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы